Gastroenterology

Gastroenterology
Gastroenterology

Gastroenterology is the branch of medicine that deals with the digestive system. The focus of this speciality is diseases of the gastrointestinal tract, which includes the organs from the mouth to the anus, including the oesophagus, stomach, small intestine, large intestine, rectum, pancreas, gallbladder, bile ducts and liver.

Janssen & Gastroenterology

Janssen’s worldwide leadership in gastroenterology has been established from a 30-year heritage of innovation and scientific breakthroughs. For over two decades, we have been a world leader in the development of treatments for patients with Inflammatory Bowel Disease (IBD) and have transformed their lives.

We foster active collaborations with academia, emerging companies, patients, and patient groups to accelerate innovation and achieve our shared goals in tackling gastroenterology-related disease.

My IBD Journey

My IBD Journey

Explore our Disease Areas

Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Disease (IBD) is a group of conditions that cause chronic (long-term or life-long) inflammation of the gastrointestinal (GI) tract, the two most common of which are Crohn’s disease (CD) and ulcerative colitis (UC).


References

NHS. Amyloidosis. Accessed May 26, 2022.
McCausland KL, White MK, Guthrie SD, et al. Light chain (AL) amyloidosis: the journey to diagnosis. The Patient-Patient-Centered Outcomes Research. 2018;11(2):207-16.
Cancer.Net. Amyloidosis: Symptoms and Signs. Accessed May 26, 2022.
Mayo Clinic. Amyloidosis overview: symptoms and causes. Accessed May 26, 2022.
National Organization for Rare Disorders. Amyloidosis. Accessed May 26, 2022.
D'Errico S, Mazzanti A, Baldari B, Maiese A, Frati P, Fineschi V. Sudden death in lambda light chain AL cardiac amyloidosis: a review of literature and update for clinicians and pathologists. Int J Clin Exp Pathol. 2020 Jul 1;13(7):1474-1482. PMID: 32782665; PMCID: PMC7414507.
Mayo Clinic. Amyloidosis diagnosis and treatment. Accessed August 20, 2020.
Lousada I, Comenzo RL, Landau H, et al. Light chain amyloidosis: patient experience survey from the Amyloidosis Research Consortium. Advances in Therapy. 2015;32(10):920-928.
Merlini G, Dispenzieri A, Sanchorawala V, et al. Systematic immunglobulin light chain amyloidosis. Nature Review Disease Primers. 2018;4(1):38.
Hasib Sidiqi M, Gertz MA. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021. Blood cancer journal. 2021;11(5):1-9.